Provided By GlobeNewswire
Last update: Oct 29, 2024
BOSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that the Company will present at two upcoming scientific conferences.
Read more at globenewswire.comNASDAQ:SNSE (9/19/2025, 8:00:02 PM)
9
-0.3 (-3.23%)
Find more stocks in the Stock Screener